Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice

Neuroscience Research

Volumn 67, Issue 1, 2010, Pages 25-32

  Zarrindast, Mohammad Reza ^a,b,c   Dorrani, Mania ^d   Lachinani, Razieh ^e   Rezayof, Ameneh ^f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Apomorphine; Hippocampus; Learning; Mice; SCH23390; Sulpiride; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; CANNABINOID 1 RECEPTOR; SULPIRIDE;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LATENT PERIOD; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RECALL; RECEPTOR BLOCKING;

ANIMALS; APOMORPHINE; AVOIDANCE LEARNING; BENZAZEPINES; BENZOXAZINES; CA1 REGION, HIPPOCAMPAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; MEMORY; MICE; MORPHOLINES; NAPHTHALENES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 77952888599     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.02.001     Document Type: Article

References (70)

1. Ahmadi S., Zarrindast M.R., Nouri M., Haeri-Rohani A., Rezayof A. N-methyl-d-aspartate receptors in the ventral tegmental area are involved in retrieval of inhibitory avoidance memory by nicotine. Neurobiol. Learn. Mem. 2007, 88:352-358.
2. Ameri A. The effects of cannabinoids on the brain. Prog. Neurobiol. 1999, 58:315-348.
3. Anderson J.J., Kask A.M., Chase T.N. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. Eur. J. Pharmacol. 1996, 295:163-168.
4. Banerjee S.P., Snyder S.H., Mecloulam R. Influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 1975, 194:74-81.
5. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
6. Bloom A.S. The effect of Δ9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 1982, 221:97-103.
7. Bohme G.A., Laville M., Ledent C., Parmentier M., Imperato A. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 2000, 95:5-7.
8. Brusco A.T., Tagliaferro P., Saez T., Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 2008, 62:944-949.
9. Carlezone J.R., Mendrek A., Wise R.A. MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation. Synapse 1995, 20:1-9.
10. Carta G., Gessa G.L., Nava F. Dopamine D(2) receptor antagonists prevent delta(9)-tetrahydrocannabinol-induced antinociception in rats. Eur. J. Pharmacol. 1999, 384:153-156.
11. Chaperon F., Thiébot M.H. Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 1999, 13:243-281.
12. Chen N., Appell M., Berfield J.L., Reith M.E. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur. J. Pharmacol. 2003, 478:89-95.
13. Clarke J.R., Rossato J.I., Monteiro S., Bevilaqua L.R., Izquierdo I., Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol. Learn. Mem. 2008, 90:374-381.
14. Collins D.R., Pertwee R.G., Davies S.N. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. 1995, 115:869-870.
15. Colpaert F.C. Amnesic trace locked into the benzodiazepine state of memory. Psychopharmacology 1990, 102:28-36.
16. Costanzi M., Battaglia M., Populin R., Cestari V., Castellano C. Anandamide and memory in CD1 mice: effects of immobilization stress and of prior experience. Neurobiol. Learn. Mem. 2003, 79:204-211.
17. Darley C.F., Tinklenberg J.R., Roth W.T., Atkinson R.C. The nature of storage deficits and state-dependent retrieval under marihuana. Psychopharmacologia 1974, 37:139-149.
18. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 2002, 42:993-1007.
19. De Oliveira Alvares L., Genro B.P., Diehl F., Quillfeldt J.A. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol. Learn. Mem. 2008, 90:1-9.
20. French E.D. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci. Lett. 1997, 226:159-162.
21. French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 1997, 8:649-652.
22. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 2005, 81:263-284.
23. Gorriti M.A., Rodríguez de Fonseca F., Navarro M., Palomo T. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur. J. Pharmacol. 1999, 365:133-142.
24. Hajos N., Freund T.F. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 2002, 43:503-510.
25. Hajos N., Ledent C., Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 2001, 106:1-4.
26. Hampson R.E., Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sci. 1999, 65:715-723.
27. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:1932-1936.
28. Izquierdo I., Medina J.H. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol. Lear. Mem. 1995, 63:19-32.
29. Kathmann M., Bauer U., Schlicker E., Göthert M. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedeberg's Arch. Pharmacol. 1999, 359:466-470.
30. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 2006, 26:2991-3001.
31. Kobilo T., Hazvi S., Dudai Y. Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory. Eur. J. Neurosci. 2007, 25:3417-3421.
32. Laviolette S.R., Grace A.A. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell. Mol. Life Sci. 2006, 63:1597-1613.
33. 5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J. Neurosci. 2006, 26:7723-7729.
34. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 1995, 119:282-290.
35. Lisman J.E., Grace A.A. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005, 46:703-713.
36. Mackie K., Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J. 2006, 28:298-306.
37. Malekmohamadi N., Heidari P., Sahebgharani M., Zarrindast M.R. Effects of clozapine and sulpiride on morphine state-dependent memory in the step-down passive avoidance test. Pharmacology 2007, 79:149-153.
38. Martín A.B., Fernandez-Espejo E., Ferrer B., Gorriti M.A., Bilbao A., Navarro M., Rodriguez de Fonseca F., Moratalla R. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 2008, 33:1667-1679.
39. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
40. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H., Damask S.P., Little K.Y., Civelli O., Watson Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 1994, 10:239-248.
41. Meschler J.P., Conley T.J., Howlett A.C. Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity. Pharmacol. Biochem. Behav. 2000, 67:567-573.
42. Meschler J.P., Clarkson F.A., Mathews P.J., Howlett A.C., Madras B.K. D2, but not D1 dopamine receptor agonists potentiate cannabinoid-induced sedation in non-human primates. J. Pharmacol. Exp. Ther. 2000, 292:952-959.
43. Moranta D., Esteban S., García-Sevilla J.A. Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain. Naunyn Schmiedeberg's Arch. Pharmacol. 2004, 369:516-524.
44. Morris R.G., Moser E.I., Riedel G., Martin S.J., Sandin J., Day M., O'Carroll C. Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003, 358:773-786.
45. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
46. Nava F., Carta G., Gessa G.L. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats. Pharmacol. Biochem. Behav. 2000, 66:183-187.
47. Nava F., Carta G., Battasi A.M., Gessa G.L. D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration. Br. J. Pharmacol. 2000, 130:1201-1210.
48. Navakkode S., Sajikumar S., Frey J.U. Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro. Neuropharmacology 2007, 52:1547-1554.
49. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994, 265:1104-1107.
50. Paton G.S., Pertwee R.G., Davies S.N. Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice. Neuropharmacology 1998, 37:1123-1130.
51. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press. 2nd ed.
52. Pettit D.A., Harrison M.P., Olson J.M., Spencer R.F., Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res. 1998, 51:391-402.
53. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl.) 2006, 188:425-544.
54. Riedel G., Davies S.N. Cannabinoid function in learning, memory and plasticity. Handb. Exp. Pharmacol. 2005, 168:445-477.
55. Rezayof A., Zarrindast M.R., Sahraei H., Haeri-Rohani A. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J. Psychopharmacol. 2003, 17:415-423.
56. Rezayof A., Motevasseli T., Rassouli Y., Zarrindast M.R. Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. Life Sci. 2007, 80:285-292.
57. Rezayof A., Alijanpour S., Zarrindast M.R., Rassouli Y. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors. Neurobiol. Learn. Mem. 2008, 89:441-447.
58. Robinson L., Goonawardena A.V., Pertwee R.G., Hampson R.E., Riedel G. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br. J. Pharmacol. 2007, 151:688-700.
59. Rodriguez de Fonseca F., Cebeira M., Fernández-Ruiz J.J., Navarro M., Ramos J.A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 1991, 43:423-713.
60. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 2001, 11:565-572.
61. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
62. Svízenská I., Dubový P., Sulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures-a short review. Biochem. Behav. 2008, 90:501-511. http://www.ncbi.nlm.nih.gov/pubmed/18584858?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2 Pharmacol.
63. Takahashi K.A., Castillo P.E. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 2006, 139:795-802.
64. Tanda G., Pontieri F.E., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997, 276:2048-2050.
65. Terranova J.P., Michaud J.C., Le Fur G., Soubrié P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 1995, 352:576-579.
66. Tran A.H., Uwano T., Kimura T., Hori E., Katsuki M., Nishijo H., Ono T. Dopamine D1 receptor modulates hippocampal representation plasticity to spatial novelty. J. Neurosci. 2008, 28:13390-13400. http://www.ncbi.nlm.nih.gov/pubmed/19074012?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=5.
67. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
68. Wu W.C., Wang Y., Chai C.Y. Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: an in vivo electrochemical study. Chin. J. Physiol. 2008, 51:152-159.
69. Zarrindast M.R., Kangarlu-Haghighi K., Khalilzadeh A., Fazli-Tabaei S. Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Behav. Pharmacol. 2006, 17:231-237.
70. Zarrindast M.R., Bananej M., Khalilzadeh A., Fazli-Tabaei S., Haeri-Rohani A., Rezayof A. Influence of intracerebroventricular administration of dopaminergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Neurobiol. Learn. Mem. 2006, 86:286-292.